Suppr超能文献

通过亲和纯化和质谱法鉴定AMP活化蛋白激酶激活剂的分子靶点

Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry.

作者信息

Kosaka Toshiyuki, Okuyama Ryo, Sun Weiyong, Ogata Tsuneaki, Harada Jun, Araki Kazushi, Izumi Masanori, Yoshida Taishi, Okuno Akira, Fujiwara Toshihiko, Ohsumi Jun, Ichikawa Kimihisa

机构信息

Biomedical Research Laboratories, Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.

出版信息

Anal Chem. 2005 Apr 1;77(7):2050-5. doi: 10.1021/ac0484631.

Abstract

We show an efficient method to identify molecular targets of small molecular compounds by affinity purification and mass spectrometry. Binding proteins were isolated from target cell lysate using affinity columns, which immobilized the active and inactive compounds. All proteins bound to these affinity columns were eluted by digestion using trypsin and then were identified by mass spectrometry. The specific binding proteins to the active compound, a candidate for molecular targets, were determined by subtracting the identified proteins in an inactive compound-immobilized affinity column from that in an active compound-immobilized affinity column. This method was applied to identification of molecular targets of D942, a furancarboxylic acid derivative, which increases glucose uptake in L6 myocytes through AMP-activated protein kinase (AMPK) activation. To elucidate the mechanism of AMPK activation by D942, affinity columns that immobilized D942 and its inactive derivative, D768, were prepared, and the binding proteins were purified from L6 cell lysate. NAD(P)H dehydrogenase [quinone] 1 (complex I), which was shown as one of the specific binding proteins to D942 by subtracting the binding proteins to D768, was partially inhibited by D942, not D768. Because inhibition of complex I activity led to a decrease in the ATP/AMP ratio, and the change in the ATP/AMP ratio triggered AMPK activation, we identified complex I as a potential protein target of AMPK activation by D942. This result shows our approach can provide crucial information about the molecular targets of small molecular compounds, especially target proteins not yet identified.

摘要

我们展示了一种通过亲和纯化和质谱法鉴定小分子化合物分子靶点的有效方法。使用亲和柱从靶细胞裂解物中分离结合蛋白,亲和柱固定了活性和非活性化合物。所有与这些亲和柱结合的蛋白质通过胰蛋白酶消化洗脱,然后通过质谱法进行鉴定。通过从固定有活性化合物的亲和柱中鉴定出的蛋白质中减去固定有非活性化合物的亲和柱中鉴定出的蛋白质,来确定与活性化合物特异性结合的蛋白质,即分子靶点的候选物。该方法应用于鉴定呋喃羧酸衍生物D942的分子靶点,D942通过激活AMP激活的蛋白激酶(AMPK)增加L6肌细胞中的葡萄糖摄取。为了阐明D942激活AMPK的机制,制备了固定D942及其非活性衍生物D768的亲和柱,并从L6细胞裂解物中纯化结合蛋白。通过减去与D768结合的蛋白质,NAD(P)H脱氢酶[醌]1(复合体I)被证明是与D942特异性结合的蛋白质之一,它被D942部分抑制,而不是D768。因为复合体I活性的抑制导致ATP/AMP比值降低,而ATP/AMP比值的变化触发AMPK激活,所以我们将复合体I鉴定为D942激活AMPK的潜在蛋白质靶点。这一结果表明我们的方法可以提供关于小分子化合物分子靶点的关键信息,特别是尚未鉴定的靶蛋白。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验